Stock ownership · SEC 13F · Q4 2025
ALNYLAM PHARMACEUTICALS INC
Who owns ALNYLAM PHARMACEUTICALS INC (CUSIP 02043Q107)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.
- $20.0M
- Reported value
- 7
- Institutions
- 100%
- Top-5 share
The verdict
According to SEC Form 13F-HR filings in this corpus, ALNYLAM PHARMACEUTICALS INC ranks #333 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders. 7 institutions report $20.0M as of Q4 2025, with ownership dominated by its top few institutional owners.
- 7
- institutions hold it
- $20.0M
- reported 13F value
- 100%
- held by top 5
- #333
- of 775 by value
Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.
According to SEC Form 13F-HR filings in this corpus, ALNYLAM PHARMACEUTICALS INC ranks #333 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders.
How 13F ownership is computed · All tracked stocks · Concentration rankings
SEC Form 13F-HR ownership desk
CUSIP 02043Q107 · Q4 2025 $20M reported
VALUE-MID · HOLDERS-FOCUS · CONC-DOM · PHOTO-FINISH · ACTIVITY-MID · BOOK-FULL
- VALUE-MID #333/775
- HOLDERS-FOCUS 7 filers
- CONC-DOM 100% top-5
- PHOTO-FINISH ARIS WATER SOLUTIONS
- ACTIVITY-MID 5 new
- BOOK-FULL 8Q history
Photo-finish peer on reported value: ARIS WATER SOLUTIONS INC
Read with: Ownership concentration guide - ALNYLAM PHARMACEUTICALS INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.
Reported-value neighbourhood · ALNYLAM PHARMACEUTICALS INC
Nearest tracked securities by aggregate 13F reported value, not a full corpus reprint.
Institutional ownership over time
The number of institutions reporting a ALNYLAM PHARMACEUTICALS INC position has risen from 4 to 7 over the last 8 quarters of 13F filings.
Top Institutional Holders
| # | Institution | Shares | Value | Share of reported |
|---|---|---|---|---|
| 1 | GROUPAMA ASSET MANAGMENT | 35,878 | $14.3M | 71.3% |
| 2 | Pacer Advisors, Inc. | 9,588 | $3.8M | 19.1% |
| 3 | Anchor Investment Management, LLC | 2,695 | $1.1M | 5.4% |
| 4 | Alpine Global Management, LLC | 2,062 | $820K | 4.1% |
| 5 | MidFirst Bank | 541 | $16K | 0.1% |
| 6 | Bell Investment Advisors, Inc | 36 | $14K | 0.1% |
| 7 | TD Capital Management LLC | 23 | $9K | 0.0% |
Investment Discretion
SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among ALNYLAM PHARMACEUTICALS INC's reported holders for Q4 2025, by reported value:
Latest Quarter Activity · Q4 2025
New positions (5)
Complete exits (8)
Frequently Asked Questions
How many institutions hold ALNYLAM PHARMACEUTICALS INC?▼
Where does ALNYLAM PHARMACEUTICALS INC sit among tracked securities?▼
What is the total institutional value of ALNYLAM PHARMACEUTICALS INC?▼
How concentrated is ownership of ALNYLAM PHARMACEUTICALS INC?▼
Who is the largest institutional holder of ALNYLAM PHARMACEUTICALS INC?▼
Nationwide stocks with similar institutional value or holder count
Two 13F-derived peer sets for ALNYLAM PHARMACEUTICALS INC: nearest aggregate reported value and nearest institutional holder count, not catalog browse links.
Similar reported value
Nearest stocks by aggregate 13F reported value ($20.0M here).
Similar holder count
Nearest stocks by number of disclosing 13F holders (7 here).
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.
PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.